ファーマ4.0の世界市場レポート2025

ファーマ4.0市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR20.8%で464億1,000万米ドルに成長します。予測期間の成長は、価値ベースのヘルスケアモデルへのシフト、高齢化とヘルスケアニーズの増加、個別化医療と精密治療への需要、規制改革とヘルスケア政策の変化、患者中心のケアとアウトカムの重視の高まりに起因すると考えられます。予測期間における主な動向には、個別化医療と精密治療、デジタルヘルス技術、価値ベースのヘルスケアモデル、規制の調和と承認プロセスの迅速化、サプライチェーンのデジタル化と透明性などがあります。

遠隔医療と遠隔患者モニタリングの拡大が、今後のファーマ4.0市場の成長を牽引すると予想されます。遠隔医療は、通信技術を通じて遠隔地から医療や診察を提供するものであり、遠隔患者モニタリングは、技術対応のデバイスやプラットフォームを使って遠隔地から患者の健康データを収集、送信、分析するものです。遠隔医療も遠隔患者モニタリングも、技術の進歩、便利なヘルスケアへのアクセスに対する需要の増加、効率的な慢性疾患管理の必要性から成長しています。これらのテクノロジーは、患者中心のケア、個別化医療のためのリアルタイムのデータ収集、医薬品開発のための製薬会社の洞察力強化などを可能にし、ファーマ4.0において重要な役割を果たしています。例えば、2022年8月のAustralian Digital Health Agencyによると、2020年3月13日から2022年7月31日までに、1億1,820万件の遠隔医療サービスが1,800万人の患者に提供され、2022年には95,000人以上の開業医が遠隔医療サービスを利用しています。したがって、遠隔医療と遠隔患者モニタリングの拡大がファーマ4.0市場の成長に寄与しています。

ファーマ4.0市場の主要プレーヤーは、クラウドベースの創薬プラットフォームなどの革新的な技術を活用して競争力を獲得しています。StarDropのようなプラットフォームは、インターネット経由でアクセス可能なクラウドホスティング環境を研究者や製薬会社に提供し、化合物スクリーニング、分子モデリング、データ解析など様々な創薬活動を可能にしています。例えば、Optibrium Ltd.は2023年10月、有名な創薬プラットフォームであるStarDropのクラウドベース・バージョンの提供を開始しました。このクラウドベースの展開は、デスクトップアプリケーションのすべての機能を保持しながら、アクセシビリティを強化し、総所有コストを削減します。Amazon Web Services（AWS）上でホストされ、Optibrium社のISO 27001認定情報セキュリティシステムによってサポートされているこのプラットフォームは、安全なデータ転送のための暗号化やファイアウォールでの保護を含む高度なデータセキュリティを保証しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ファーマ4.0 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のファーマ4.0市場：成長率分析
• 世界のファーマ4.0市場の実績：規模と成長, 2019-2024
• 世界のファーマ4.0市場の予測：規模と成長, 2024-2029, 2034F
• 世界ファーマ4.0総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のファーマ4.0市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハードウェア
• ソフトウェア
• サービス
• 世界のファーマ4.0市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クラウドコンピューティング
• 人工知能（AI）
• ビッグデータ分析
• モノのインターネット（IoT）
• 世界のファーマ4.0市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品の発見と開発
• 臨床試験
• 製造業
• 世界のファーマ4.0市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• バイオテクノロジー企業
• 契約調査機関（CRO）
• 契約製造組織（CMO）
• 世界のファーマ4.0市場、ハードウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• センサー
• 産業用ロボット
• PLC（プログラマブルロジックコントローラー）
• IoTデバイス
• SCADA（監視制御およびデータ収集）システム
• その他の自動化機器
• 世界のファーマ4.0市場、ソフトウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エンタープライズリソースプランニング（ERP）ソフトウェア
• 製造実行システム（MES）
• ラボ情報管理システム（LIMS）
• サプライチェーン管理ソフトウェア
• 予知保全ソフトウェア
• データ分析と人工知能（AI）ソフトウェア
• クラウドベースのソリューション
• サイバーセキュリティソフトウェア
• 世界のファーマ4.0市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 統合および実装サービス
• マネージドサービス
• トレーニングおよびサポートサービス
• メンテナンスおよび修理サービス

第7章 地域別・国別分析

• 世界のファーマ4.0市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のファーマ4.0市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ファーマ4.0市場：競合情勢
• ファーマ4.0市場：企業プロファイル
  • Alphabet Inc Overview, Products and Services, Strategy and Financial Analysis
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Amazon Web Services Inc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Roche Holding AG
• International Business Machines Corporation
• Merck & Co. Inc
• Cisco Systems Inc
• Bristol Myers Squibb Company
• Oracle Corporation
• AstraZeneca PLC
• Novartis International AG
• GlaxoSmithKline plc
• Honeywell International Inc
• Fujitsu Limited
• ABB Ltd
• Siemens Healthineers
• GE Healthcare
• Lotte Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ファーマ4.0市場2029：新たな機会を提供する国
• ファーマ4.0市場2029：新たな機会を提供するセグメント
• ファーマ4.0市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharma 4.0, also termed Pharmaceutical 4.0, signifies the integration of advanced digital technologies within the pharmaceutical sector, akin to the broader concept of Industry 4.0. It represents a transformative approach to pharmaceutical manufacturing and healthcare delivery, aimed at addressing challenges such as rising costs, regulatory compliance, drug shortages, and the demand for personalized treatments. Moreover, it aims to unlock new avenues for innovation while enhancing patient care.

The primary components of Pharma 4.0 include hardware, software, and services. Hardware refers to the physical components of computer systems or electronic devices, encompassing elements such as processors, memory, storage, and peripherals. Various cutting-edge technologies, including cloud computing, artificial intelligence (AI), big data analytics, and the Internet of Things (IoT), are leveraged across numerous applications within the pharmaceutical sector, ranging from drug discovery and development to clinical trials and manufacturing processes. Pharma 4.0 solutions find application across a diverse range of end-users, primarily including pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and contract manufacturing organizations (CMOs).

The pharma 4.0 market research report is one of a series of new reports from The Business Research Company that provides pharma 4.0 market statistics, including pharma 4.0 industry global market size, regional shares, competitors with a pharma 4.0 market share, detailed pharma 4.0 market segments, market trends and opportunities, and any further data you may need to thrive in the pharma 4.0 industry. This pharma 4.0 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma 4.0 market size has grown exponentially in recent years. It will grow from $17.99 billion in 2024 to $21.77 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to regulatory compliance and quality assurance, drug patent expirations and generic competition, increasing healthcare expenditure, demand for personalized medicine and biologics, globalization of pharmaceutical markets.

The pharma 4.0 market size is expected to see exponential growth in the next few years. It will grow to $46.41 billion in 2029 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to shift towards value-based healthcare models, aging population and increased healthcare needs, demand for personalized medicine and precision therapeutics, regulatory reforms and changes in healthcare policies, growing emphasis on patient-centric care and outcomes. Major trends in the forecast period include personalized medicine and precision therapeutics, digital health technologies, value-based healthcare models, regulatory harmonization and accelerated approval processes, supply chain digitization and transparency.

The expansion of telemedicine and remote patient monitoring is expected to drive the growth of the Pharma 4.0 market moving forward. Telemedicine involves providing medical care and consultations remotely through telecommunications technology, while remote patient monitoring collects, transmits, and analyzes patient health data from a distance using technology-enabled devices and platforms. Both telemedicine and remote patient monitoring are growing due to technological advancements, increasing demand for convenient healthcare access, and the need for efficient chronic disease management. These technologies play vital roles in Pharma 4.0 by enabling patient-centered care, real-time data collection for personalized medicine, and enhancing pharmaceutical companies' ability to gather insights for drug development. For example, according to the Australian Digital Health Agency in August 2022, from 13 March 2020 to 31 July 2022, 118.2 million telehealth services were delivered to 18 million patients, with over 95,000 practitioners using telehealth services in 2022. Therefore, the expansion of telemedicine and remote patient monitoring is contributing to the growth of the Pharma 4.0 market.

Key players in the pharma 4.0 market are leveraging innovative technologies such as cloud-based drug discovery platforms to gain a competitive edge. Platforms such as StarDrop offer researchers and pharmaceutical companies cloud-hosted environments accessible via the Internet, enabling various drug discovery activities such as compound screening, molecular modeling, and data analysis. For example, Optibrium Ltd. launched a cloud-based version of its renowned drug discovery platform, StarDrop, in October 2023. This cloud-based deployment enhances accessibility and reduces total ownership costs while retaining all functionalities of the desktop application. Hosted on Amazon Web Services (AWS) and supported by Optibrium's ISO 27001-accredited information security system, the platform ensures advanced data security, including encryption for secure data transfer and protection behind a firewall.

In June 2022, ProductLife Group bolstered its presence in the pharma 4.0 market through the acquisition of Pharma IT ApS. This strategic move aims to enhance ProductLife Group's market position, particularly in Northern Europe, and expand its service offerings in life sciences digitalization. Pharma IT ApS, a Denmark-based consulting company specializing in life sciences, brings valuable expertise in consulting services for the medical device, biotech, and pharmaceutical industries, strengthening ProductLife Group's capabilities in catering to the evolving needs of the pharma 4.0 landscape.

Major companies operating in the pharma 4.0 market are Alphabet Inc., Microsoft Corporation, Pfizer Inc., Johnson & Johnson, Amazon Web Services Inc., Roche Holding AG, International Business Machines Corporation, Merck & Co. Inc., Cisco Systems Inc., Bristol Myers Squibb Company, Oracle Corporation, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, ABB Ltd., Siemens Healthineers, GE Healthcare, Lotte Corporation, SAS Institute Inc., Optum Inc., POLARISqb, Syntekabio, Optibrium

North America was the largest region in the pharma 4.0 market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma 4.0 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharma 4.0 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma 4.0 market consists of revenues earned by entities by providing services such as remote patient monitoring, virtual consultations, digital therapeutics, and medication adherence programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The Pharma 4.0 market also includes sales of digital twin platforms, smart manufacturing systems, patient engagement tools, and monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma 4.0 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma 4.0 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma 4.0 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma 4.0 market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Technology: Cloud Computing; Artificial Intelligence (Al); Big Data Analytics; Internet of Things (IoT)
• 3) By Application: Drug Discovery And Development; Clinical Trials; Manufacturing
• 4) By End-User: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
• Subsegments:
• 1) By Hardware: Sensors; Industrial Robots; PLC (Programmable Logic Controllers); IoT Devices; SCADA (Supervisory Control And Data Acquisition) Systems; Other Automation Equipment
• 2) By Software: Enterprise Resource Planning (ERP) Software; Manufacturing Execution Systems (MES); Lab Information Management Systems (LIMS); Supply Chain Management Software; Predictive Maintenance Software; Data Analytics And Artificial Intelligence (AI) Software; Cloud-based Solutions; Cybersecurity Software
• 3) By Services: Consulting Services; Integration And Implementation Services; Managed Services; Training And Support Services; Maintenance And Repair Services
• Companies Mentioned: Alphabet Inc; Microsoft Corporation; Pfizer Inc; Johnson & Johnson; Amazon Web Services Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharma 4.0 Market Characteristics

3. Pharma 4.0 Market Trends And Strategies

4. Pharma 4.0 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharma 4.0 Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharma 4.0 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharma 4.0 Market Growth Rate Analysis
• 5.4. Global Pharma 4.0 Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharma 4.0 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharma 4.0 Total Addressable Market (TAM)

6. Pharma 4.0 Market Segmentation

• 6.1. Global Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware
• Software
• Services
• 6.2. Global Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud Computing
• Artificial Intelligence (AI)
• Big Data Analytics
• Internet of Things (IoT)
• 6.3. Global Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Development
• Clinical Trials
• Manufacturing
• 6.4. Global Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Contract Manufacturing Organizations (CMOs)
• 6.5. Global Pharma 4.0 Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sensors
• Industrial Robots
• PLC (Programmable Logic Controllers)
• IoT Devices
• SCADA (Supervisory Control And Data Acquisition) Systems
• Other Automation Equipment
• 6.6. Global Pharma 4.0 Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enterprise Resource Planning (ERP) Software
• Manufacturing Execution Systems (MES)
• Lab Information Management Systems (LIMS)
• Supply Chain Management Software
• Predictive Maintenance Software
• Data Analytics And Artificial Intelligence (AI) Software
• Cloud-based Solutions
• Cybersecurity Software
• 6.7. Global Pharma 4.0 Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Integration And Implementation Services
• Managed Services
• Training And Support Services
• Maintenance And Repair Services

7. Pharma 4.0 Market Regional And Country Analysis

• 7.1. Global Pharma 4.0 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharma 4.0 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharma 4.0 Market

• 8.1. Asia-Pacific Pharma 4.0 Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharma 4.0 Market

• 9.1. China Pharma 4.0 Market Overview
• 9.2. China Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharma 4.0 Market

• 10.1. India Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharma 4.0 Market

• 11.1. Japan Pharma 4.0 Market Overview
• 11.2. Japan Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharma 4.0 Market

• 12.1. Australia Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharma 4.0 Market

• 13.1. Indonesia Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharma 4.0 Market

• 14.1. South Korea Pharma 4.0 Market Overview
• 14.2. South Korea Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharma 4.0 Market

• 15.1. Western Europe Pharma 4.0 Market Overview
• 15.2. Western Europe Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharma 4.0 Market

• 16.1. UK Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharma 4.0 Market

• 17.1. Germany Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharma 4.0 Market

• 18.1. France Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharma 4.0 Market

• 19.1. Italy Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharma 4.0 Market

• 20.1. Spain Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharma 4.0 Market

• 21.1. Eastern Europe Pharma 4.0 Market Overview
• 21.2. Eastern Europe Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharma 4.0 Market

• 22.1. Russia Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharma 4.0 Market

• 23.1. North America Pharma 4.0 Market Overview
• 23.2. North America Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharma 4.0 Market

• 24.1. USA Pharma 4.0 Market Overview
• 24.2. USA Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharma 4.0 Market

• 25.1. Canada Pharma 4.0 Market Overview
• 25.2. Canada Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharma 4.0 Market

• 26.1. South America Pharma 4.0 Market Overview
• 26.2. South America Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharma 4.0 Market

• 27.1. Brazil Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharma 4.0 Market

• 28.1. Middle East Pharma 4.0 Market Overview
• 28.2. Middle East Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharma 4.0 Market

• 29.1. Africa Pharma 4.0 Market Overview
• 29.2. Africa Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharma 4.0 Market Competitive Landscape And Company Profiles

• 30.1. Pharma 4.0 Market Competitive Landscape
• 30.2. Pharma 4.0 Market Company Profiles
  • 30.2.1. Alphabet Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Amazon Web Services Inc Overview, Products and Services, Strategy and Financial Analysis

31. Pharma 4.0 Market Other Major And Innovative Companies

• 31.1. Roche Holding AG
• 31.2. International Business Machines Corporation
• 31.3. Merck & Co. Inc
• 31.4. Cisco Systems Inc
• 31.5. Bristol Myers Squibb Company
• 31.6. Oracle Corporation
• 31.7. AstraZeneca PLC
• 31.8. Novartis International AG
• 31.9. GlaxoSmithKline plc
• 31.10. Honeywell International Inc
• 31.11. Fujitsu Limited
• 31.12. ABB Ltd
• 31.13. Siemens Healthineers
• 31.14. GE Healthcare
• 31.15. Lotte Corporation

32. Global Pharma 4.0 Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma 4.0 Market

34. Recent Developments In The Pharma 4.0 Market

35. Pharma 4.0 Market High Potential Countries, Segments and Strategies

• 35.1 Pharma 4.0 Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharma 4.0 Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharma 4.0 Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer